Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Thornton

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Muscle Research and Cell Motility|December 26, 2002
Six and Eya expression during human somitogenesis and MyoD gene family activationFrançoise Fougerousse, Muriel Durand, Soledad Lopez, et al.
Muscle & Nerve|January 13, 2018
Myotonic dystrophy patient preferences in patient-reported outcome measuresChad Heatwole, Nicholas Johnson, Jeanne Dekdebrun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® StudyTanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
Muscle & Nerve|October 22, 2013
Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measureChad Heatwole, Rita Bode, Nicholas Johnson, et al.
Neurology. Clinical Practice|October 5, 2019
Consensus-based care recommendations for adults with myotonic dystrophy type 2Benedikt Schoser, Federica Montagnese, Guillaume Bassez, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation-Sponsored WorkshopSharon Hesterlee, Shashi Amur, Lisa J Bain, et al.
Neurology|November 20, 2015
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)Chad Heatwole, Nicholas Johnson, Rita Bode, et al.
Human Molecular Genetics|December 19, 2018
Transcriptome alterations in myotonic dystrophy skeletal muscle and heartEric T Wang, Daniel Treacy, Katy Eichinger, et al.
Muscle & Nerve|June 6, 2015
Myotonic dystrophy health index: Correlations with clinical tests and patient functionChad Heatwole, Rita Bode, Nicholas E Johnson, et al.
Neurology|October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled TrialChad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Muscle Research and Cell Motility|December 26, 2002
Six and Eya expression during human somitogenesis and MyoD gene family activationFrançoise Fougerousse, Muriel Durand, Soledad Lopez, et al.
Muscle & Nerve|January 13, 2018
Myotonic dystrophy patient preferences in patient-reported outcome measuresChad Heatwole, Nicholas Johnson, Jeanne Dekdebrun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® StudyTanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
Muscle & Nerve|October 22, 2013
Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measureChad Heatwole, Rita Bode, Nicholas Johnson, et al.
Neurology. Clinical Practice|October 5, 2019
Consensus-based care recommendations for adults with myotonic dystrophy type 2Benedikt Schoser, Federica Montagnese, Guillaume Bassez, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation-Sponsored WorkshopSharon Hesterlee, Shashi Amur, Lisa J Bain, et al.
Neurology|November 20, 2015
Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2)Chad Heatwole, Nicholas Johnson, Rita Bode, et al.
Human Molecular Genetics|December 19, 2018
Transcriptome alterations in myotonic dystrophy skeletal muscle and heartEric T Wang, Daniel Treacy, Katy Eichinger, et al.
Muscle & Nerve|June 6, 2015
Myotonic dystrophy health index: Correlations with clinical tests and patient functionChad Heatwole, Rita Bode, Nicholas E Johnson, et al.
Neurology|October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled TrialChad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
Pageof 2